Clinical Trials
3 trialsNCT05725200 2023-02-21
EVIDENT
Oslo University Hospital
Phase 2 Recruiting
NCT02890069 2023-01-11
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Novartis
Phase 1 Completed
NCT00690677 2012-01-18
Phase II Trial of LBH589 in Refractory Colorectal Cancer
Swedish Medical Center
Phase 2 Completed